277 related articles for article (PubMed ID: 20926645)
21. Suppression of intestinal tumorigenesis in
Wolfe AR; Ernlund A; McGuinness W; Lehmann C; Carl K; Balmaceda N; Neufeld KL
J Cell Sci; 2017 Feb; 130(4):805-813. PubMed ID: 28082422
[TBL] [Abstract][Full Text] [Related]
22. The C-terminus of Apc does not influence intestinal adenoma development or progression.
Lewis A; Davis H; Deheragoda M; Pollard P; Nye E; Jeffery R; Segditsas S; East P; Poulsom R; Stamp G; Wright N; Tomlinson I
J Pathol; 2012 Jan; 226(1):73-83. PubMed ID: 22009253
[TBL] [Abstract][Full Text] [Related]
23. Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation.
Radulescu S; Ridgway RA; Cordero J; Athineos D; Salgueiro P; Poulsom R; Neumann J; Jung A; Patel S; Woodgett J; Barker N; Pritchard DM; Oien K; Sansom OJ
Oncogene; 2013 Apr; 32(16):2048-57. PubMed ID: 22665058
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.
Su LK; Barnes CJ; Yao W; Qi Y; Lynch PM; Steinbach G
Am J Hum Genet; 2000 Sep; 67(3):582-90. PubMed ID: 10924409
[TBL] [Abstract][Full Text] [Related]
25. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.
Yang K; Popova NV; Yang WC; Lozonschi I; Tadesse S; Kent S; Bancroft L; Matise I; Cormier RT; Scherer SJ; Edelmann W; Lipkin M; Augenlicht L; Velcich A
Cancer Res; 2008 Sep; 68(18):7313-22. PubMed ID: 18794118
[TBL] [Abstract][Full Text] [Related]
26. Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene.
Senda T; Shimomura A; Iizuka-Kogo A
Anat Sci Int; 2005 Sep; 80(3):121-31. PubMed ID: 16158975
[TBL] [Abstract][Full Text] [Related]
27. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
[TBL] [Abstract][Full Text] [Related]
28. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
[TBL] [Abstract][Full Text] [Related]
29. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
30. Complete deletion of Apc results in severe polyposis in mice.
Cheung AF; Carter AM; Kostova KK; Woodruff JF; Crowley D; Bronson RT; Haigis KM; Jacks T
Oncogene; 2010 Mar; 29(12):1857-64. PubMed ID: 20010873
[TBL] [Abstract][Full Text] [Related]
31. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
Groves C; Lamlum H; Crabtree M; Williamson J; Taylor C; Bass S; Cuthbert-Heavens D; Hodgson S; Phillips R; Tomlinson I
Am J Pathol; 2002 Jun; 160(6):2055-61. PubMed ID: 12057910
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
33. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A
Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464
[TBL] [Abstract][Full Text] [Related]
34. APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.
Latchford A; Volikos E; Johnson V; Rogers P; Suraweera N; Tomlinson I; Phillips R; Silver A
Hum Mol Genet; 2007 Jan; 16(1):78-82. PubMed ID: 17135276
[TBL] [Abstract][Full Text] [Related]
35. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
Hu PJ; Knoepp SM; Wu R; Cho KR
Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.
D'Orazio D; Muller PY; Heinimann K; Albrecht C; Bendik I; Herzog U; Tondelli P; Bauerfeind P; Müller H; Dobbie Z
Anticancer Res; 2002; 22(6A):3409-14. PubMed ID: 12530096
[TBL] [Abstract][Full Text] [Related]
37. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
[TBL] [Abstract][Full Text] [Related]
38. Stem cell markers characterise familial adenomatous polyposis.
Wang T; Yeoh KG; Salto-Tellez M
Gut; 2012 May; 61(5):785-6. PubMed ID: 21873735
[No Abstract] [Full Text] [Related]
39. APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.
Zhang T; Ahn K; Emerick B; Modarai SR; Opdenaker LM; Palazzo J; Schleiniger G; Fields JZ; Boman BM
PLoS One; 2020; 15(10):e0239601. PubMed ID: 33112876
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]